Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...

Now, in a major step forward, an international clinical trial has found three new safe and effective drug regimens for ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...

Tuberculosis remains one of the top infectious disease killers worldwide , a challenge amplified by drug-resistant forms of the disease. Now, in a ...

Rifampin-resistant tuberculosis has traditionally been treated with 18-to-24-month regimens, but shorter, all-oral regimens may offer efficacious alternatives. New research findings are summarized ...